Apyx Medical Corporation APYX
Set alert
2.60 USD -0.09 -3.35%
At close · Oct 30
2.60 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
2.53 Day range 2.65
2.36 52-week range 4.86
- YTD
- -25.71%
- 1 year
- -11.86%
- Open
- 2.65
- Prev close
- 2.69
- Mkt cap
- 109.52M
- Vol
- 38.09K
- Avg vol
- 143.17K
- EPS
- -0.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.53
- High
- 2.65
- Forward P/E
- -3.39
- Beta
- 1.21
- Short ratio
- 5.49
- Inst. own
- 40.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.41
- 200-d avg
- 1.39
- 1y target
- 2.83
Financial health
Altman Z-Score
0.84 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -13.0×
FY 2016 5y median -4.9× FY 2025
P/S 2.8×
FY 2016 5y median 1.8× FY 2025
P/B 10.1×
FY 2016 5y median 4.0× FY 2025
P/FCF -16.2×
FY 2016 5y median -15.7× FY 2025
EV/EBITDA -33.8×
FY 2016 5y median -4.7× FY 2025
EV/Sales 2.9×
FY 2016 5y median 1.6× FY 2025
FCF Yield -6.2%
FY 2016 5y median -6.4% FY 2025
Profitability
Gross Margin 36.0%
FY 2016 5y median 64.5% FY 2025
Operating Margin -12.2%
FY 2016 5y median -33.0% FY 2025
Net Margin -21.2%
FY 2016 5y median -35.7% FY 2025
ROE -77.1%
FY 2016 5y median -70.1% FY 2025
ROIC -11.6%
FY 2016 5y median -25.9% FY 2025
ROA -16.8%
FY 2016 5y median -23.6% FY 2025
Growth (YoY)
Revenue 9.9%
FY 2016 FY 2025
Operating Income 65.8%
FY 2016 FY 2025
EPS (diluted) 59.1%
FY 2016 FY 2025
Free Cash Flow 51.4%
FY 2016 FY 2025
Financial Health
Current Ratio 5.0×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 4.3×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 2.7×
FY 2016 5y median 1.4× FY 2025
Net Debt / EBITDA -1.7×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -1.2×
FY 2016 5y median -7.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31